slides · global inventory
Problem Statement Canvas
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,665
Current window 1,861-1,890
Pages 89
Rows per page 30
Tool
1,861-1,890 of 2,665
05
The diagram shows a circular, inefficient optimization process (affinity, developability, toxicity) leading to suboptimal candidates.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The slide uses a comparison framework to contrast the data availability between small molecule and biologic drug discovery.Absci | Investor Conference Presentation Deck | 21 slides · absci
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
24
The slide uses a biological process diagram to contrast normal intracellular metabolism with the therapeutic effect of the drug in the plasma.Aeglea BioTherapeutics | Investor Day Presentation Deck | 28 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done1 hit
03
Uses a combination of pie charts for global stats and a process diagram for supply chain loss.AgroFresh | Investor Presentation Deck | 20 slides · AgroFresh
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
11
The slide uses a hub-and-spoke/process flow hybrid to visualize systemic complexity and administrative burden.Apollo Medical Holdings | Investor Presentation Deck | 45 slides · Apollo Medical Holdings
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
34
The slide uses a visual layout with three circular metrics to emphasize the scale of the problem.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Confession1 hit
20
Includes a visual representation of drug mechanism in the body.AstraZeneca | Results Presentation Deck | 44 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
05
Uses a two-column layout to contrast 'Significant Burden' with 'Urgent Need for Innovation'.ATAI | Investor Presentation Deck | 41 slides · atai Life Sciences
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
BenevolentAI | Investor Presentation Deck | 46 slidesBenevolentAI | Investor Presentation Deck | 46 slides · BenevolentAI
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
25
Berkeley Lights | Investor Day Presentation Deck | 91 slidesBerkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Need1 hit
32
This is a transition or setup slide for a technical solution.Berkeley Lights | Investor Day Presentation Deck | 91 slides · Berkeley Lights
Conference presentation Investor relations Beat · Need1 hit
29
Mentions a specific cost range ($300k-$450k) as a pain point for current CAR-T therapies.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
23
The slide uses a histology image to visually demonstrate negative TUSC2 expression in SCLC.Genprex | Investor Presentation Deck | 39 slides · Genprex
Pitch deck Investor relations 1 hit
08
Uses a biological analogy (brake pedal) to explain gene function.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Need1 hit
23
Includes a histological image showing negative TUSC2 expression.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations 1 hit
11
The slide uses a process diagram to show disease progression and three columns to define the specific conditions.Hepion Pharmaceuticals | Results Presentation Deck | 34 slides · Hepion Pharmaceuticals
Pitch deck Investor relations 1 hit
09
IGI | IPO Presentation Deck | 23 slidesIGI | IPO Presentation Deck | 23 slides · IGI
Regulatory filing Investment bank Beat · Problem1 hit
27
The slide uses a numbered list format to categorize three distinct trends under the 'Human Capital' theme.Kinnevik | Investor Event Presentation Deck | 40 slides · Kinnevik
Conference presentation Investor relations Beat · Visualization1 hit
11
The diagram uses a hub-and-spoke model to define the 'ideal' product profile.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
17
The slide uses a process diagram to illustrate the CAR T cell lifecycle and the microenvironment, followed by a table mapping obstacles to solutions.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Loop · Logic Chain1 hit
54
Mink Therapeutics | Investor Day Presentation Deck | 92 slidesMink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
65
The diagram illustrates the biological mechanism of iNKT cells interacting with other immune cells (DC, MDSC, Inflammatory Monocyte) to control secondary bacterial pneumonia and inflammation.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations 1 hit
05
The slide uses a 'problem-solution' structure, contrasting current systemic failures with the VBC model.P3 Health Partners | Investor Conference Presentation Deck | 20 slides · P3 Health Partners
Conference presentation Investor relations 1 hit
13
The slide uses a background map of the world to emphasize the global nature of the condition, despite the specific US prevalence statistic.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
08
Includes a screenshot of a BMC Neurology paper and a bar chart showing subgroup analysis of OHSA scores.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
33
The slide uses a biological mechanism diagram to illustrate the drug's effect on norepinephrine reuptake.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
04
The slide uses a central hub-and-spoke diagram to show the mast cell as the central point of failure/intervention.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
The slide outlines a randomized, placebo-controlled trial structure with specific weeks and days for allergen challenges and measurements.Third Harmonic Bio | Investor Presentation Deck | 20 slides · Third Harmonic Bio
Pitch deck Investor relations 1 hit
15
Slide provides a high-level summary of a pharmaceutical asset's profile and development roadmap.Tonix Pharmaceuticals | Investor Presentation Deck | 29 slides · Tonix Pharmaceuticals
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit